Clinical Trial

Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this project is to test non-invasive, painless skin electrical bioimpedance (BioZ) measurements as an adjunctive biomarker to standard bone marrow biopsies.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-03 -> 2027-07 2026-07-09
minor Completion pushed: 2027-03 -> 2027-07 2026-07-09
Trial Details
NCT Number NCT07570056
Lead Sponsor University of Utah
Conditions Myelodysplastic Syndromes, Acute Myeloid Leukemia
Enrollment 25 participants
Start Date 2026-08
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-06